What Is Oxytocin? Benefits, Research & Safety

Oxytocin's history dates to the early 20th century. Sir Henry Dale first described its uterine-contracting properties in 1906, naming it from the Greek words meaning "swift birth." He later received the Nobel Prize in 1936 for related discoveries. In 1953, Vincent du Vigneaud determined oxytocin's chemical structure and subsequently synthesised it, becoming the first polypeptide hormone to be synthesised. This achievement earned him the Nobel Prize in Chemistry in 1955. Synthetic oxytocin became widely used in obstetric medicine, where it remains a cornerstone for labour induction and management of postpartum haemorrhage. Interest in oxytocin's behavioural effects accelerated in the 1990s and 2000s with studies in prairie voles revealing its role in pair bonding. Research by Tom Insel and others demonstrated that oxytocin was crucial for monogamous bonding in these animals. Human research expanded dramatically, with studies examining oxytocin's effects on trust, social cognition, and emotional processing. Intranasal oxytocin became a popular research tool, though methodological questions about central delivery remain. Current research continues to explore therapeutic applications in autism, anxiety, PTSD, and other conditions, while also recognising the complexity of oxytocin's effects across different social contexts.